HighTower Advisors, LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 165 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q4 2020$13,891,000
+25.8%
951,437
+22.4%
0.06%
+9.4%
Q3 2020$11,041,000
-23.1%
777,570
-20.3%
0.05%
-32.1%
Q2 2020$14,359,000
+51.9%
976,122
-57.4%
0.08%
+27.9%
Q1 2020$9,450,000
-13.5%
2,293,136
+0.9%
0.06%
-6.2%
Q4 2019$10,928,000
-23.1%
2,271,836
-3.1%
0.06%
-15.6%
Q3 2019$14,208,000
-16.2%
2,344,647
-10.2%
0.08%
-23.8%
Q2 2019$16,950,000
-5.9%
2,611,855
+2.8%
0.10%
-15.8%
Q1 2019$18,009,000
+60.1%
2,540,041
+9.7%
0.12%
+39.5%
Q4 2018$11,250,000
-34.5%
2,314,931
-0.9%
0.09%
-30.6%
Q3 2018$17,179,000
+16.3%
2,337,132
+0.9%
0.12%
+6.9%
Q2 2018$14,775,000
+14.5%
2,315,747
-2.4%
0.12%
+7.4%
Q1 2018$12,909,000
+31.4%
2,373,298
+0.7%
0.11%
+33.3%
Q4 2017$9,826,000
-56.8%
2,355,942
-0.2%
0.08%
-58.2%
Q3 2017$22,737,000
-18.6%
2,360,9840.0%0.19%
-22.4%
Q2 2017$27,930,000
+4.0%
2,360,984
+12.7%
0.25%
-2.7%
Q1 2017$26,846,000
+4.7%
2,094,0150.0%0.26%
-7.6%
Q4 2016$25,631,000
+4.7%
2,094,015
+0.9%
0.28%
-2.1%
Q3 2016$24,477,000
+5973.7%
2,074,347
+4380.1%
0.28%
+5580.0%
Q2 2016$403,000
+70.8%
46,301
+3.5%
0.01%
+400.0%
Q1 2016$236,000
-31.8%
44,7210.0%0.00%
-75.0%
Q4 2015$346,000
+8.5%
44,721
+10.3%
0.00%0.0%
Q3 2015$319,000
-6.2%
40,533
+8.0%
0.00%
-20.0%
Q2 2015$340,000
-10.5%
37,533
+28.1%
0.01%
-16.7%
Q1 2015$380,000
+55.1%
29,296
+62.8%
0.01%
+50.0%
Q4 2014$245,000
+129.0%
17,998
+51.2%
0.00%
+100.0%
Q3 2014$107,000
-33.5%
11,9050.0%0.00%
-33.3%
Q2 2014$161,000
+36.4%
11,9050.0%0.00%
+50.0%
Q1 2014$118,000
-25.3%
11,9050.0%0.00%
-33.3%
Q4 2013$158,000
+9.0%
11,9050.0%0.00%
-25.0%
Q3 2013$145,000
+17.9%
11,9050.0%0.00%
+33.3%
Q2 2013$123,00011,9050.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,365,000$16,186,0001.49%
CADIAN CAPITAL MANAGEMENT, LP 5,517,767$26,540,0001.17%
NEEDHAM INVESTMENT MANAGEMENT LLC 1,590,000$7,646,0001.04%
Parkman Healthcare Partners LLC 420,000$2,020,0000.58%
Penn Capital Management Company, LLC 977,526$4,702,0000.49%
Bullseye Asset Management LLC 79,272$381,0000.37%
Bellevue Group AG 2,441,241$11,742,0000.19%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,783$1,447,0000.18%
Granite Investment Partners, LLC 589,313$2,835,0000.13%
WRAPMANAGER INC 68,163$328,0000.10%
View complete list of GENMARK DIAGNOSTICS INC shareholders